📣 VC round data is live. Check it out!

Biohit Valuation Multiples

Discover revenue and EBITDA valuation multiples for Biohit and similar public comparables like Baumer, Mentice, Bio-Works Technologies, Accuray and more.

Biohit Overview

About Biohit

Biohit Oyj is a biotechnology company. It manufactures products that bind acetaldehyde, diagnostic products, and systems for diagnostic analysis for the use of research institutions, healthcare, and industry. Biohit's product portfolio consists of diagnostic tests, analysis systems, products that bind carcinogenic acetaldehyde into harmless compounds and monoclonal antibodies and service laboratory operations.


Founded

1988

HQ

Finland

Employees

46

Financials (FY)

Revenue: $18M
EBITDA: $4M

EV

$41M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Biohit Financials

Biohit reported last fiscal year revenue of $18M and EBITDA of $4M.

In the same fiscal year, Biohit generated $13M in gross profit, $4M in EBITDA, and $3M in net income.

Revenue (LTM)


Biohit P&L

In the most recent fiscal year, Biohit reported revenue of $18M and EBITDA of $4M.

Biohit is profitable as of last fiscal year, with gross margin of 68%, EBITDA margin of 21%, and net margin of 17%.

See analyst estimates for Biohit
Last FY202320242025202620272028
Revenue$18M$15M$17M$18M
Gross Profit$13M$10M$11M$13M
Gross Margin68%63%65%68%
EBITDA$4M$3M$4M$4M
EBITDA Margin21%21%25%21%
EBIT Margin20%13%18%20%
Net Profit$3M$2M$3M$3M
Net Margin17%14%18%17%

Financial data powered by Morningstar, Inc.

Biohit Stock Performance

Biohit has current market cap of $44M, and enterprise value of $41M.

Market Cap Evolution


Biohit's stock price is $2.92.

Biohit share price decreased by 1.6% in the last 30 days, and by 9.3% in the last year.

Biohit has an EPS (earnings per share) of $0.21.

See more trading valuation data for Biohit
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$41M$44M5.9%-1.6%-0.3%-9.3%$0.21

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Biohit Valuation Multiples

Biohit trades at 2.2x EV/Revenue multiple, and 10.4x EV/EBITDA.

See NTM and 2027E valuation multiples for Biohit

EV / Revenue (LTM)


Biohit Financial Valuation Multiples

As of May 29, 2026, Biohit has market cap of $44M and EV of $41M.

Biohit has a P/E ratio of 13.9x.

Last FY202320242025202620272028
EV/Revenue2.2x2.7x2.4x2.2x
EV/EBITDA10.4x13.0x10.0x10.4x
EV/EBIT10.9x21.2x13.7x10.9x
EV/Gross Profit3.2x4.2x3.7x3.2x
P/E13.9x20.6x14.9x13.9x
EV/FCF(25.6x)53.4x189.7x(25.6x)

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Biohit Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Biohit Margins & Growth Rates

In the most recent fiscal year, Biohit reported gross margin of 68%, EBITDA margin of 21%, and net margin of 17%.

See estimated margins and future growth rates for Biohit

Biohit Margins

Last FY20242025202720282029
Gross Margin68%65%68%
EBITDA Margin21%25%21%
EBIT Margin20%18%20%
Net Margin17%18%17%
FCF Margin(9%)1%(9%)

Biohit Growth Rates

23/2424/2526/2727/2828/29
Revenue Growth9%10%
Gross Profit Growth13%15%
EBITDA Growth30%(4%)
EBIT Growth55%25%
Net Profit Growth39%7%
FCF Growth(72%)(841%)

Data powered by FactSet, Inc. and Morningstar, Inc.

Biohit Operational KPIs

Biohit's revenue per employee in the last FY averaged $0.4M, while opex per employee averaged $0.2M for the same period.

Access forward-looking KPIs for Biohit
Last FY202320242025202620272028
Revenue per Employee$0.4M---
Opex per Employee$0.2M---
S&M Expenses to Revenue4%4%4%4%
Opex to Revenue48%51%47%48%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Baumer0.8x-3.8x-
Mentice1.3x1.3x86.7x32.0x
Bio-Works Technologies6.1x-(23.1x)-
Accuray0.4x0.5x6.7x55.0x
RenovoRx26.8x15.3x(2.4x)-
Baird Medical Investment2.9x-(2.7x)-
InspireMD0.4x0.3x(0.1x)(0.1x)
Nutriband13.6x13.6x(4.6x)-

This data is available for Pro users. Sign up to see all Biohit competitors and their valuation data.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Biohit

When was Biohit founded?Biohit was founded in 1988.
Where is Biohit headquartered?Biohit is headquartered in Finland.
How many employees does Biohit have?As of today, Biohit has over 46 employees.
Is Biohit publicly listed?Yes, Biohit is a public company listed on Nasdaq Helsinki.
What is the stock symbol of Biohit?Biohit trades under BIOBV ticker.
When did Biohit go public?Biohit went public in 1999.
Who are competitors of Biohit?Biohit main competitors include Baumer, Mentice, Bio-Works Technologies, Accuray, RenovoRx, Baird Medical Investment, InspireMD, Nutriband, Mauna Kea Technologies, Abingdon Health.
What is the current market cap of Biohit?Biohit's current market cap is $44M.
What is the current revenue of Biohit?Biohit's last fiscal year revenue is $18M.
What is the current EV/Revenue multiple of Biohit?Current revenue multiple of Biohit is 2.2x.
Is Biohit profitable?No, Biohit is not profitable.
How many companies Biohit has acquired to date?Biohit hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies Biohit has invested to date?Biohit hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Biohit

Lists including Biohit

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial